Introduction: Nutraceutical is a term applied for a plethora of products ranging from isolated nutrients, herbal products to dietary supplements and recently, the interest for a nutraceutical approach to lipid and metabolic disorders is growing. Patients with metabolic conditions seem to appreciate a therapeutic management that does not involve drug treatment, particularly for the side effects due to statins, a class of drug used for lipid disorders. Statins directly induce skeletal muscle injury and in elderly patients, under polytherapy treatments, this risk relies to an increase of adverse drug reactions due to drug interactions.
INTRODUCTION
Nutraceutical is a term applied for a plethora of products ranging from functional foods (i.e. products that beneficially affect one or more target functions in the body, beyond adequate nutritional effects), food supplements (i.e. concentrated source of nutrients or other substances with a nutritional or physiological effect) to dietary foods (i.e. complete foods with a standard nutrient formulation which may constitute the only source of nourishment for a designed person), able to provide health benefits [1] .
Even if their use is increasing among the general population, very low data have been published concerning their safety. In a recent paper, Geller and coworkers [2] evaluating surveillance data from 63 emergency departments in the United States obtained from 2004 through 2013, estimated that 23,005 emergency department visits/year were attributed to adverse events related to dietary supplements.
The risk of an adverse event is related to age of the patient but also to the co administered drug. In fact, recently Felix et al. [3] , reported that the potential for the *Address correspondence to this author at the Department of Health Science, School of Medicine, University of Catanzaro, Clinical Pharmacology Unit, Mater Domini University Hospital, Viale EuropaGermaneto 88100 Catanzaro, Italy.; Tel: +39-0961-712322; Fax: +39-0961-774424; E-mail: gallelli@unicz.it development of adverse drug reactions during the treatment with dietary supplements can be amplified in elderly patients or those taking multiple prescription drugs; this may be related with the development of drug interactions (DIs) involving all the phases of the pharmacokinetic of each drug.
It has been reported that hypolipidemic supplements, such as monacolin K, are also able to evocate myopathy and rhabdomyolysis [4] . Here we report a case where a nutraceutical (Armolipid plus®) reinforced drug side effects inducing rhabdomyolysis by DI in an elderly patient. Pharmacological assessment revealed the possible relationship among sertraline, rosuvastatin and red yeast rice (present in the dietary supplement). Using the Drug Interaction Probability Scale (DIPS) [5] , we estimated that the DI among the active ingredients mentioned above, was probably involved in the development of rhabdomyolysis (DIPS score: 5). Therefore both rosuvastatin and the dietary supplement were discontinued, while sertraline was changed to escitalopram (10 mg o.d.; daily dose 10 mg) because it shows a low risk of drug interactions. One month later (29 th November), during the follow-up, clinical and laboratory finding revealed a complete remission of both, clinical symptoms and biochemical parameters (see Table 1 
CASE SUMMARY

DISCUSSION
In this case, we report the development of rhabdomyolysis possibly related to a drug-nutraceutical interaction. Previously, we documented the development of generalized dermatitis and itch induced by a possible drugfood interaction [6] , moreover, we also reported that both sertraline and rosuvastatin are able to induce rhabdomyolysis [7, 8] .
In our patient, the co-administration of sertraline (150 mg/day), rosuvastatin (5 mg/day) and of dietary supplement (1 Since benefits of statins are well documented [9] , myopathy or rhabdomyolysis, have been associated with the use of statins; this effect is dose-related [10] and could be associated with pharmacokinetic interactions [8] .
On the other hand, the development of myopathy and rhabdomyolysis was also described in patients treated with monacolin K [4] . It is worth to note that red yeast rice contains monacolin K that has the identical biochemical/pharmacological action of lovastatin and is able per se to induce rhabdomyolysis [11, 12] .
Moreover, recently Philibert et al., [13] evaluating the French national pharmacovigilance database and in scientific literature, documented the development of muscular disorders in patients treated with monacolin K.
Even if yeast rice and rosuvastatin, have a direct effect on skeletal muscle tissue, other drugs such as benzodiazepines, antihistamines, barbiturates and antidepressants, are also able to predispose patients to the development of rhabdomyolysis [14] .
In the present case, our patient received a treatment with Selective Serotonin-Reuptake Inhibitors (SSRIs). Labotz and coworkers [15] reported the development of rhabdomyolysis in three patients treated with SSRIs after performing 15 sets of 15 repetitions of maximal eccentric contractions of the elbow flexors, suggesting that SSRIs may represent a predisposing factor to muscle injury after eccentric exercise. Moreover, Gareri and co-workers [7] reported a 71-year-old woman with co-morbidity that developed rhabdomyolysis after the administration of sertraline (50 mg/day), supporting a role of sertraline in the development of this ADR probably related to genetic factor (e.g. Genetic defects of sertraline demethylation and/or P-glycoprotein binding).
Finally, the development of rhabdomyolysis may also be related to drug overuse. In fact, in a retrospective study Wilson et al., [16] documented the development of acute muscle injury in patients who ingested larger quantities of venlafaxine (mean 2800 mg/day).
However, the development of rhabdomyolysis was also documented in a 21-year-old woman treated with low dosages of venlafaxine (37.5 mg/day) [17] . Biochemical laboratory parameters recorded in a 70-year-old woman at the time of the first examination ( In our patient, we can exclude a role of exercise as a factor able to increase the risk of rhabdomyolysis. Furthermore we cannot rule-out that this ADR might be related to genetic factors, involving the absorption and the metabolism and the of the drugs (e.g. cytochrome P450 and P-glycoprotein polymorphisms) [18] . However, we did not perform the therapeutic drug monitoring of drugs therefore we cannot exclude a drug overuse, and this represents a limit of this case, even if the patient and her parents referred to the use of standard dosage of each drug.
The discontinuation of both rosuvastatin and dietary supplement and the change of sertraline to escitalopram induced the complete remission of the clinical symptoms, and using the DIPS scale we postulated that a DI probable induced the development of rhabdomyolysis.
Although, nutraceuticals are over-the-counter drugs, without doubt they are not less dangerous than others due to their pharmacokinetic and pharmacodynamic interactions and our patient reported that she was taking the dietary supplement without her physician's consultation. The present case is indicative for an inappropriate use of a dietary supplement to whoever was already under rosuvastatin and sertraline treatments.
The type of study, case report, represents another limit of this presentation and post-marketing drug safety surveillance data (e.g. voluntary spontaneous reports of adverse events from consumers and health care professionals) are necessary to validate this observation. However, we think that a surveillance system for a closer monitoring of the safety of nutraceutical substances may be useful to evaluate their safety in particular types of patients, i.e. elderly and patients in poly-therapy.
This case report highlights how pharmacological treatment must be periodically reassessed, since elderly people could take drugs by themselves when they do not need them. The reassessing of the therapy could also improve elderly patient's psychological comfort, their quality of life and costs for their assistance. In fact, in agreement with our previously reports, the development of ADRs due to an inappropriate use, is an alert for physicians/pharmacists in order to carefully evaluate the coadministration of drugs and dietary supplements [19] . This concern is particularly important for elderly people, who often take a relevant daily number of drugs.
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